Returning as the only event created selectively for and by the TCR community, the 6th TCR-based Therapies Summit (April 1-3, 2025 | Boston, MA) is your unique opportunity to connect and collaborate with TCR developers and experts to battle the specific discovery, preclinical and clinical challenges created by T cell receptor biology to advance cell- and bispecific approaches.
View the full lineup of presenting companies in the 2025 Event Guide.
Returning as a much-loved forum by industry leaders in this close-knit community, I’m sure you want to know what’s new for the 2025 meeting:
- Plethora of new data: Over 60% of talks will share new data, including clinical insights and advances, novel target case studies, and innovations utilizing AI, machine learning, engineering methods, and cell tracking
- Breadth of TCR Approaches: Uncover the realm of TCR targeting methods including TCR-Ts, TCR-NKs, bispecifics, T-cell engagers, TCR-like antibodies, and mimics, and distinguishing the optimal approach for different indications
- 7 New Companies & 85% New Speakers: Unlock innovations from companies such as Moonlight Bio, Synteny, Alkemist Bio, Pan Cancer T, and Aethon Therapeutics making their TCR-Based Therapies Summit debut and hear new perspectives from a highly refreshed speaker faculty
- Applications Beyond Oncology: Discover how TCR therapies can be utilized to treat novel indications, such as autoimmunity and infectious diseases, and harness cross-learnings to propel your therapeutic development
Following Adaptimmune’s milestone approval, the 2025 meeting is anticipated to be one of the best yet. With so much to celebrate, momentum to capture, novel insights, and collaboration with like-minded experts at the only TCR-specific event.
Quick links: Website | Event Guide | Register